XML 77 R47.htm IDEA: XBRL DOCUMENT v3.20.1
Shareholders' Equity (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 11 Months Ended 12 Months Ended
May 08, 2019
shares
Dec. 18, 2018
USD ($)
$ / shares
shares
Jul. 09, 2018
USD ($)
Jun. 05, 2018
$ / shares
shares
Feb. 29, 2020
USD ($)
$ / shares
shares
Mar. 31, 2019
USD ($)
$ / shares
shares
Jun. 09, 2020
USD ($)
shares
Mar. 31, 2020
USD ($)
$ / shares
shares
Mar. 31, 2020
USD ($)
$ / shares
shares
Mar. 31, 2019
USD ($)
$ / shares
shares
Apr. 30, 2020
USD ($)
Jun. 22, 2018
USD ($)
Mar. 31, 2018
shares
Class of Stock [Line Items]                          
Common shares authorized (in shares) | shares           1,000,000,000   1,000,000,000 1,000,000,000 1,000,000,000      
Common shares par value (in dollars per share) | $ / shares           $ 0.00001   $ 0.00001 $ 0.00001 $ 0.00001      
Stock split ratio 0.125             0.125          
Capital contribution | $                 $ 148 $ 1,894      
Public Offering                          
Class of Stock [Line Items]                          
Common stock issued during period (in shares) | shares   4,145,115     16,631,336 3,333,333              
Common stock issued (in dollars per share) | $ / shares   $ 8       $ 12   $ 3.75 $ 3.75 $ 12      
Net proceeds from common stock issued | $   $ 31,600     $ 70,800 $ 37,900              
Gross proceeds from common stock issued | $   $ 33,200       $ 40,000              
Warrants issued (in shares) | shares         3,301,998                
Warrants issued (in dollars per share) | $ / shares         $ 3.74999                
Percent ownership threshold to no longer exercise         9.99%                
Underwriter's Option                          
Class of Stock [Line Items]                          
Common stock issued during period (in shares) | shares   395,115     2,600,000                
Roivant Sciences, Ltd. | Public Offering                          
Class of Stock [Line Items]                          
Common stock issued during period (in shares) | shares   1,250,000     5,333,333 833,333              
Roivant Sciences, Ltd. | Private Placement                          
Class of Stock [Line Items]                          
Common stock issued during period (in shares) | shares       1,785,714                  
Common stock issued (in dollars per share) | $ / shares       $ 14                  
Net proceeds from common stock issued | $     $ 25,000                    
Cowen and Company, LLC | Private Placement                          
Class of Stock [Line Items]                          
Amount available for issuance under equity offering program | $               $ 100 $ 100        
Maximum offering under equity offering program | $                       $ 75,000  
RSL                          
Class of Stock [Line Items]                          
Capital contribution | $                 $ 100 $ 1,900      
Common Shares                          
Class of Stock [Line Items]                          
Shares outstanding before split (in shares) | shares 182,200,000                        
Shares outstanding (in shares) | shares           22,779,891   39,526,299 39,526,299 22,779,891     13,473,512
Subsequent Event | SVB Leerink LLC | Private Placement                          
Class of Stock [Line Items]                          
Common stock issued during period (in shares) | shares             900,000            
Net proceeds from common stock issued | $             $ 2,700            
Maximum offering under equity offering program | $                     $ 25,000    
Percentage of gross proceeds from common stock issuance paid for services                     3.00%